Conditions: Head and Neck Cancer Squamous Cell Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 90
Healthy volunteers: no

Brief summary:
Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study.

Detailed description:

Arms:
arm 1: Zalutumumab iv infusion once weekly. The dose was titrated until grade 2 rash occurred.

Interventions: intervention 1: Zalutumumab
Intervention descriptions: intervention 1: Individual dose titration weekly i.v. doses

Protocol document: